C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/1999
12/22/1999	EP0965586A1 Method of purifying carbazole ester precursors of 6-chloro-alpha-methyl-carbazole-2-acetic acid
12/22/1999	EP0964865A2 Pharmaceutically active tricyclic amines
12/22/1999	EP0964863A1 Oxazolidines as 5-ht2a-antagonists
12/22/1999	EP0964852A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
12/22/1999	EP0964851A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion
12/22/1999	EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999	EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders
12/22/1999	EP0765858B1 Naphthol derivatives and process for producing the same
12/22/1999	EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/22/1999	CN1047592C Tinctorial compsn. of 5,6-dihydroxyindole and yeing method of keratose fibre
12/21/1999	US6005085 Condensed azo compounds and process for preparing the same
12/21/1999	US6004991 Compounds for cosmetics with enantiomorphs
12/21/1999	US6004536 Lipophilic cyanine dyes with enchanced aqueous solubilty
12/16/1999	WO1999064519A1 Energy transfer assay method and reagent
12/16/1999	WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999	WO1999064398A1 Quarternary ammonium compounds as anti-tussive agents
12/16/1999	WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064043A1 Muscarinic receptor antagonists
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999050268A3 Substituted indolealkanoic acids
12/16/1999	WO1999043651A3 Inhibitors of phospholipase enzymes
12/16/1999	CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2334454A1 Quarternary ammonium compounds as anti-tussive agents
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2315883A1 Muscarinic receptor antagonists
12/15/1999	EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999	EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999	EP0963981A1 Biaryl heterocyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
12/15/1999	CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999	CN1238760A N-(aryl/heteroaryl/alkyl acetyl) amino acid esters, pharmaceutical composition comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/15/1999	CN1047386C Novel spiro [indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
12/15/1999	CN1047385C 3-indolylpiperidine and medinal composition containing them
12/15/1999	CN1047384C Synthetic process of Ramipril
12/15/1999	CN1047383C Process for preparation of aldehydes
12/14/1999	US6002018 N-substituted 4-hydroxyindoline derivatives
12/14/1999	US6002003 Cyanine dye activating group with improved coupling selectivity
12/14/1999	US6001998 Macrocyclic lactone compounds and their production process
12/14/1999	US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension
12/14/1999	US6001877 Of given formula, which acts as an antagonist of leukotrienes; administering to treat leukotriene-b4 induced diseases, such as allergies and inflammation
12/14/1999	US6001837 Methods of treating or preventing sleep apnea
12/14/1999	US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent
12/12/1999	CA2274638A1 Aromatic heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions made thereof and uses
12/09/1999	WO1999062962A1 Novel photoinitiators and applications therefor
12/09/1999	WO1999062899A1 Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition
12/09/1999	WO1999062890A1 Isothiazole derivatives useful as anticancer agents
12/09/1999	WO1999062882A1 Substituted indolinones, the production thereof and their use as medicaments
12/09/1999	WO1999062867A1 Indan derivatives
12/09/1999	WO1999062520A1 Hiv integrase inhibitors
12/09/1999	WO1999062513A1 Hiv integrase inhibitors
12/09/1999	WO1999062503A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
12/09/1999	WO1999051591A3 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
12/09/1999	WO1999043650A3 Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
12/09/1999	DE19825557A1 Enzymatic production of 4-hydroxy-dibenzopyrrole derivatives useful as pharmaceutical intermediates
12/09/1999	DE19824922A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
12/09/1999	CA2334412A1 Indan derivatives
12/09/1999	CA2333707A1 Hiv integrase inhibitors
12/09/1999	CA2333661A1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
12/09/1999	CA2329134A1 Hiv integrase inhibitors
12/09/1999	CA2328291A1 Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions

1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 458